Evidence map›Paper›PMID 40778741›Full record

ArticleFuture microbiology2025

Isavuconazole activity against

Bruna Rodrigues de Sousa, Camylla Carvalho de Melo, Manoel Marques Evangelista Oliveira, Sylvia Maria de Lemos Hinrichsen, Rossana de Aguiar Cordeiro, Reginaldo Gonçalves de Lima-Neto

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bruna Rodrigues de SousaTropical Medicine, Center for Medical Sciences, Federal University of Pernambuco (UFPE), Recife, Brazil.
Camylla Carvalho de MeloTropical Medicine, Center for Medical Sciences, Federal University of Pernambuco (UFPE), Recife, Brazil.
Manoel Marques Evangelista OliveiraLaboratory of Taxonomy, Biochemistry and Bioprospecting of Fungi, Oswaldo Cruz Institute (FIOCRUZ), Rio de Janeiro, Brazil.
Sylvia Maria de Lemos HinrichsenCenter for Medical Sciences, Federal University of Pernambuco (UFPE), Recife, Brazil.
Rossana de Aguiar CordeiroDepartment of Pathology and Forensic Medicine, Federal University of Ceará (UFC), Fortaleza, Brazil.ORCID 0000-0001-8386-2180
Reginaldo Gonçalves de Lima-NetoTropical Medicine, Center for Medical Sciences, Federal University of Pernambuco (UFPE), Recife, Brazil.ORCID 0000-0002-8846-877X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe evaluated the

methodsA total of 102 strains of

resultsThe species identified were

conclusionBoth methodologies were useful for evaluating the antifungal potential of isavuconazole and highlighted the low MICs of this triazole against the Brazilian collection of

Indexed as

Antifungal AgentsCandidaCandida aurisCandidiasisNitrilesPyridinesTriazolesBrazilHumansMicrobial Sensitivity TestsAntifungal AgentsisavuconazoleNitrilesPyridinesTriazolesAntifungal susceptibility testingbroth microdilutionCandida aurisisavuconazoleMICyeasts

Identifiers

PMID40778741
PMCPMC12645856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.